Condition
OSAS (Obstructive Sleep Apneas Syndrome)
Total Trials
5
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Recruiting2
Not Yet Recruiting1
Enrolling By Invitation1
Unknown1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07493629Recruiting
Immune Status and Disease Control of Inflammatory Airway Diseases
NCT07459322Not ApplicableNot Yet RecruitingPrimary
The Use of Remimazolam Versus Dexmedetomidine for Patients Receiving Drug-Induced Sleep Endoscopy
NCT07312136Enrolling By Invitation
MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study
NCT06971874Recruiting
The Outcome of Chronic Kidney Disease Patients With Obstructive Sleep Apnea Syndrome
NCT00646477Phase 3UnknownPrimary
ISIS 1 Therapeutic Effectiveness
Showing all 5 trials